Lv1
40 积分 2024-04-29 加入
An in situ engineered chimeric IL-2 receptor potentiates the tumoricidal activity of proinflammatory CAR macrophages in renal cell carcinoma
3天前
已完结
A pathology foundation model for cancer diagnosis and prognosis prediction
5个月前
已完结
Major AlphaFold upgrade offers boost for drug discovery
1年前
已完结
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer
1年前
已完结
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma
1年前
已完结
Holmium Laser Enucleation of the Prostate Following Previous Prostatic Urethral Lift
1年前
已完结
皖公网安备34019202002308
